Comparative molecular characterization of typical and exceptional responders in glioblastoma

Glioblastoma (GBM) is the most common and the deadliest type of primary brain tumor, with a median survival time of only 15 months despite aggressive treatment. Although most patients have an extremely poor prognosis, a relatively small number of patients survive far beyond the median survival time....

Descripción completa

Detalles Bibliográficos
Autores principales: Wipfler, Kristin, Cornish, Adam S., Guda, Chittibabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033343/
https://www.ncbi.nlm.nih.gov/pubmed/29983870
http://dx.doi.org/10.18632/oncotarget.25420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033343/
https://www.ncbi.nlm.nih.gov/pubmed/29983870
http://dx.doi.org/10.18632/oncotarget.25420

Ejemplares similares